Literature DB >> 34384323

Excavating the pathogenic gene of breast cancer based on high throughput data of tumor and somatic reprogramming.

Lian Duan1,2, Zhendong Wang3, Xin Zheng1,4,5, Junjian Li1,4,5, Huamin Yin1,4,5, Weibo Tang4,5,6, Dejian Deng4,5,6, Hui Liu6, Jiayu Wei7, Yan Jin8,9, Feng Liu2, Jingling Shen4,5.   

Abstract

Breast cancer (BC) is one of the most common malignancies in female, and has a high mortality rate. The mechanisms of tumorigenesis and reprogramming of somatic cells have a certain degree of similarity. Here, we focus on the relationship between gene expression, signaling pathways and functions in BC compared to induced pluripotent stem cells (iPSCs). We first identified differentially expressed genes (DEGs) common to BC and iPSCs in datasets from GEO and TCGA. We found 22 DEGs that were significantly associated with clinicopathological features and prognosis by performing Kaplan-Meier survival analysis and one-way ANOVA. The results of protein mass spectrometry of tumor stem cells (Mcfips) demonstrated that the proteins encoded by 8 of these DEGs were also differentially expressed. The functional enrichment analysis showed that most of the 30 DEGs were related to collagen and chromatin functions. Our results might offer targets for future studies into the mechanisms underlying tumor occurrence and progression, and our studies could provide valuable data for both basic research and clinical applications of BC.

Entities:  

Keywords:  Breast cancer; clinicopathological features; gene expression; induced pluripotent stem cells; protein

Mesh:

Substances:

Year:  2021        PMID: 34384323      PMCID: PMC8489947          DOI: 10.1080/15384101.2021.1961410

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   5.173


  45 in total

1.  High Oct-ane fuel powers the stem cell.

Authors:  P J Donovan
Journal:  Nat Genet       Date:  2001-11       Impact factor: 38.330

2.  A fresh look at iPS cells.

Authors:  Shinya Yamanaka
Journal:  Cell       Date:  2009-04-03       Impact factor: 41.582

3.  A nationwide study of breast cancer, depression, and multimorbidity among hospitalized women and men in the United States.

Authors:  Roger J Zoorob; Jason L Salemi; Maria C Mejia de Grubb; Sanjukta Modak; Robert S Levine
Journal:  Breast Cancer Res Treat       Date:  2018-11-21       Impact factor: 4.872

4.  Malignant pleural effusion cells show aberrant glucose metabolism gene expression.

Authors:  C-C Lin; L-C Chen; V S Tseng; J-J Yan; W-W Lai; W-P Su; C-H Lin; C-Y F Huang; W-C Su
Journal:  Eur Respir J       Date:  2010-09-30       Impact factor: 16.671

5.  Energy metabolism in human pluripotent stem cells and their differentiated counterparts.

Authors:  Sandra Varum; Ana S Rodrigues; Michelle B Moura; Olga Momcilovic; Charles A Easley; João Ramalho-Santos; Bennett Van Houten; Gerald Schatten
Journal:  PLoS One       Date:  2011-06-17       Impact factor: 3.240

Review 6.  Chromatin signatures of cancer.

Authors:  Marc A Morgan; Ali Shilatifard
Journal:  Genes Dev       Date:  2015-02-01       Impact factor: 11.361

7.  In epithelial cancers, aberrant COL17A1 promoter methylation predicts its misexpression and increased invasion.

Authors:  Pulari U Thangavelu; Tibor Krenács; Eloise Dray; Pascal H G Duijf
Journal:  Clin Epigenetics       Date:  2016-11-18       Impact factor: 6.551

8.  Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts.

Authors:  Federica Guffanti; Maddalena Fratelli; Monica Ganzinelli; Marco Bolis; Francesca Ricci; Francesca Bizzaro; Rosaria Chilà; Federica Paola Sina; Robert Fruscio; Michela Lupia; Ugo Cavallaro; Maria Rosa Cappelletti; Daniele Generali; Raffaella Giavazzi; Giovanna Damia
Journal:  Oncotarget       Date:  2018-05-15

9.  Enpp1: a potential facilitator of breast cancer bone metastasis.

Authors:  Wen Min Lau; Michele Doucet; Ryan Stadel; David Huang; Kristy L Weber; Scott L Kominsky
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

10.  A hnRNP K⁻AR-Related Signature Reflects Progression toward Castration-Resistant Prostate Cancer.

Authors:  Matteo Capaia; Ilaria Granata; Mario Guarracino; Andrea Petretto; Elvira Inglese; Carlo Cattrini; Nicoletta Ferrari; Francesco Boccardo; Paola Barboro
Journal:  Int J Mol Sci       Date:  2018-06-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.